from other drugs, and may therefore be preferable for pharmacokinetic studies, but a spectrophotometric procedure is suitable for round-the-clock management of acute asthmatic emergencies, as well as chronic care. The procedure described eliminates the most important and common source of interference, can be completed in 20-30 mm, and is technically suited for emergency and routine use.
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Anal.
Chem. 45, 2403 (1973 When serum was both treated with dextran-coated charcoal and dialyzed, dialysis and reconstitution were performed first. After treatment, we froze the serum for several weeks before we used it. When hormone-depleted serum was used in the radioimmunoassay for immunoreactive insulin, the original serum was obtained from healthy adults after an overnight fast. When hormone-depleted serum was tested for loss of hormones after treatment with dextrancoated charcoal and (or) dialysis, serum was also obtained postprandially, so that relatively large amounts of endogenous insulin would be present.
Assessment of hormone-depletion.

1311-labeled insulin
(51 Ci/g) and '251-labeled growth hormone (60 Ci/g; Abbott
Laboratories, North
Chicago, Ill. 60064) were added to serum before treatment with dextran-coated charcoal and (or) dialysis and the loss of radioactivity was measured after treatment. In addition, loss of endogenous insulin and growth hormone (somatotropin) was assessed by radioimmunoassays for insulin (5) and growth hormone (6) wherein the unknown serum is diluted at least 20-fold in the final incubation mixture and the assay does not depend on a second-antibody reaction.
Effect of hormone-depleted serum on the double-antibody radioimmunoassay
of immunoreactive insulin. Standard curves were prepared by use of known amounts of insulin following the method of a commonly used doubleantibody radioimmunoassay for immunoreactive insulin (7), which, like many others (8, 9) is a modification of the method of Morgan and Lazarow (1) . Unknown sera are usually assayed relatively undiluted in these assays. In the assay used here (7), unknown sera were assayed at a final twofold dilution during incubation. A standard curve prepared by use of insulin standard diluted in a borate buffer containing bovine serum albumin (7) was compared to a standard curve in which some of the borate buffer/albumin solution was replaced by thawed hormone-depleted serum. The amount of hormone-depleted serum used was equal to the amount of human serum used when assaying an unknown sample. As carrier protein to assist precipitation, we used normal guinea pig serum in the separation step in both standard curves. A single human insulin standard was used (generously donated by the Lilly Research Laboratories; lot No. 516-73-33). Table 1 shows that 90% or more of added radiolabeled insulin or growth hormone--or of endogenous insulin (two initial concentrations) or endogenous growth hormone-is removed by dextran-coated charcoal or dialysis, or both.
Results
Similar results were obtained with other samples. Figure 1 shows the effect of hormone-depleted serum on the standard curve.' Addition of depleted serum increased the amount of radiolabeled insulin in the precipitate at each concentration of unlabeled insulin standard, indicating that a given amount of unlabeled insulin displaced less radiolabeled insulin from its antibody. The resulting shift in the standard curve would increase the apparent insulin value of an unknown sample of serum by an average of 64% (Table 2) .
Discussion
The values obtained in radioimmunoassays may differ from the actual values because of uncontrolled variables.
Thus, values obtained with different methods or in differ-
ent laboratories may not be comparable. An example of an uncontrolled variable is our previous finding that the absolute value of serum insulin may differ with different standard insulins of human origin (10) . Therefore, in a given assay the standard curve and the unknown serum being assayed should be tested under conditions as similar as possible. When this is done in a commonly used radioimmunoassay for insulin, and hormone-depleted serum is included in the standard curve, our findings indicate that the absolute has an effect, hormone-depleted serum should be routinely used in the standard curve of the assay.
The clinical use of an assay for serum insulin often requires that the absolute value be measured, because a diagnosis may depend on the serum insulin being more or less than a given concentration (3) . Thus the assay should be performed in a strictly standardized manner in which the standard curve mimics the unknown serum as closely as possible. Hormone-depleted serum is easily prepared and helps allow this to be done. Moreover, the use of hormonedepleted serum and the eventual use of a standard reference preparation of human insulin may allow results from one laboratory to be compared more meaningfully to those from another laboratory and to published values. Such a comparison is not now possible unless the laboratories involved actually exchange samples, a cumbersome practice for widespread use and one which may reveal unexpected differences rather than similarities in insulin values (11) . A valid comparison would still depend on a sufficiently detailed description of the assay, which is often omitted (3, 12, 13) .
